Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
New Hampshire Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Neonmind Biosciences Inc
(OP:
NMDBF
)
N/A
UNCHANGED
Last Price
Updated: 10:22 AM EST, Dec 14, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Neonmind Biosciences Inc
NeonMind Announces Plan to Launch 10 Clinics for Innovative Treatments as Mental Health Crisis Grows
April 12, 2022
Partnered with SRx Health Solutions and BioScript Solutions to Build Out a Network of NeonMind-branded Specialty Mental Health Clinics Across Canada OAKVILLE, ON / ACCESSWIRE / April 12, 2022 /...
From
NeonMind Biosciences Inc.
Via
AccessWire
NeonMind to Present at H.C. Wainwright 2nd Annual Psychedelics Virtual Conference
December 02, 2021
VANCOUVER, BC / ACCESSWIRE / December 2, 2021 / NeonMind Biosciences Inc. (CSE:NEON) (OTCQB:NMDBF) (FRA:6UF) ("NeonMind'' or the "Company"), an integrated drug development and wellness company focused...
From
NeonMind Biosciences Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
NeonMind Announces Successful Completion of Pre-IND Consultation with FDA on Clinical Path for Obesity Drug Candidate NEO-001
November 23, 2021
- FDA feedback provides clear clinical path for NEO-001, the first obesity drug therapy focused on neuropharmacological and behavioral changes for sustainable weight loss - Company plans to file an IND...
From
NeonMind Biosciences Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
NeonMind to Participate in Panel Discussion at Lift & Co. Expo's Psychedelics Business Summit on November 19, 2021
November 17, 2021
VANCOUVER, BC / ACCESSWIRE / November 17, 2021 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FRA:6UF) ("NeonMind'' or the "Company"), an integrated drug development and wellness company, is...
From
NeonMind Biosciences Inc.
Via
AccessWire
Topics
Cannabis
Intellectual Property
Exposures
Cannabis
Intellectual Property
NeonMind and SRx Health Solutions Announce Strategic Alliance to Establish Specialty Mental Health Clinics for Interventional Psychiatry Treatments
November 08, 2021
VANCOUVER, BC / ACCESSWIRE / November 8, 2021 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FRA:6UF) ("NeonMind'' or the "Company"), an integrated drug development and wellness company, today...
From
NeonMind Biosciences Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
NeonMind Biosciences Named as a Top Industry Innovator in Inaugural Issue of Psychedelia Magazine
November 05, 2021
Announces Participation in Microdose's Wonderland: Miami on November 8-9, 2021 VANCOUVER, BC / ACCESSWIRE / November 5, 2021 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FRA:6UF) ("NeonMind"),...
From
NeonMind Biosciences Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
NeonMind Advances Strategy for Specialty Clinic Launch
September 28, 2021
Company expects to launch first specialty clinic locations by early 2022 NeonMind-branded specialty mental health clinics to bring innovative interventional psychiatry treatments to underserved...
From
NeonMind Biosciences Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
NeonMind Strengthens its Specialty Clinics Advisory Board with Appointment of Mood Disorders and Ketamine Expert Dr. Gustavo Vazquez, MD, PhD.
September 22, 2021
Company Continues to Expand Its Scientific Expertise with Noted Expert in Utilizing Ketamine for Treatment Resistant Depression VANCOUVER, BC / ACCESSWIRE / September 22, 2021 / NeonMind Biosciences...
From
NeonMind Biosciences Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
NeonMind Appoints Ketamine and Neurostimulation Expert Dr. Roumen Milev, MD, PhD to Specialty Clinic Advisory Board
September 16, 2021
Company Broadens Scientific Expertise with Addition of Mental Health Expert in Setting Up and Managing Interventional Psychiatric Clinics VANCOUVER, BC / ACCESSWIRE / September 16, 2021 / NeonMind...
From
NeonMind Biosciences Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
NeonMind Announces Divestiture of Consumer Related and Other Non-Core Assets
September 13, 2021
Reflects Strategic Focus on Psychedelic Treatments with Major Milestones in 2021 VANCOUVER, BC / ACCESSWIRE / September 13, 2021 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FRA:6UF)...
From
NeonMind Biosciences Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
NeonMind to Present at H.C. Wainwright 23rd Annual Global Investment Conference
September 08, 2021
VANCOUVER, BC / ACCESSWIRE / September 8, 2021 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FRA:6UF) ("NeonMind''or the "Company"), an integrated drug development and wellness company focused on...
From
NeonMind Biosciences Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
NeonMind Announces DTC Eligibility
August 25, 2021
VANCOUVER, BC / ACCESSWIRE / August 25, 2021 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FFE:6UF) ("NeonMind'' or the "Company"), an integrated drug development and wellness company focused on...
From
NeonMind Biosciences Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
NeonMind Receives Health Canada Approval for its Functional Mushroom Formulation 'Mindful Blend'
August 17, 2021
VANCOUVER, BC / ACCESSWIRE / August 17, 2021 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FFE:6UF) ("NeonMind'' or the "Company"), an integrated drug development and wellness company focused on...
From
NeonMind Biosciences Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
NeonMind Announces Corporate Update and Strategic Reorganization of its Pharmaceutical Division
August 05, 2021
- Designed to Accelerate Execution of Integrated Drug Development Plan for NEO-001 to Treat Obesity - Establishes R&D Advisory Board, Appoints Philippe Martin as Chairman - Expands Regulatory...
From
NeonMind Biosciences Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
Dr. Sagar Parikh, MD Appointed to NeonMind Specialty Clinics Advisory Board
July 28, 2021
VANCOUVER, BC / ACCESSWIRE / July 28, 2021 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FFE:6UF) ("NeonMind'' or the "Company"), an integrated drug development and wellness company focused on...
From
NeonMind Biosciences Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
NeonMind Provides Integrated Drug Development Plan Update for NEO-001 to Treat Obesity
July 21, 2021
- Target Product Profile and Clinical Phase 1/2 Study Aim To Address Deficiencies In Chronic Weight Management - Pre-IND Meeting in the U.S. and Pre-CTA Consultation Meeting in Canada Targeted for...
From
NeonMind Biosciences Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
NeonMind Announces Launch of Functional Mushroom Coffees as Dietary Supplements in the US
June 29, 2021
VANCOUVER, BC / ACCESSWIRE / June 29, 2021 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FRA:6UF) ("NeonMind'' or the "Company"), a psychedelic drug development company, is pleased to announce...
From
NeonMind Biosciences Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
NeonMind to Present at H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference
June 14, 2021
Vancouver, British Columbia--(Newsfile Corp. - June 14, 2021) - NeonMind Biosciences Inc. (CSE: NEON) (OTCQB: NMDBF) (FSE: 6UF) ("NeonMind" or...
Via
Newsfile
Topics
Intellectual Property
Exposures
Intellectual Property
NeonMind Announces Vitasave Will Carry NeonMind Functional Mushroom Products
June 10, 2021
Vancouver, British Columbia--(Newsfile Corp. - June 10, 2021) - NeonMind Biosciences Inc. (CSE: NEON) (OTCQB: NMDBF) (FSE: 6UF) ("NeonMind"), is...
Via
Newsfile
Topics
Intellectual Property
Exposures
Intellectual Property
NeonMind to Commence Trading on the OTCQB Venture Market
May 28, 2021
Vancouver, British Columbia--(Newsfile Corp. - May 28, 2021) - NeonMind Biosciences Inc. (CSE: NEON) (OTCQB: NMDBF) (FFE: 6UF) ("NeonMind"), an...
Via
Newsfile
Topics
Intellectual Property
Exposures
Intellectual Property
BTV Explores Investment Options in Life Sciences
May 06, 2021
Vancouver, British Columbia--(Newsfile Corp. - May 6, 2021) - On national TV Sat. May 8 & Sun. May 9, 2021...
Via
Newsfile
Exposures
COVID-19
NeonMind Announces New Specialty Clinics Division to Deliver Innovative Mental Health Services, Appoints New VP, Corporate Development
April 22, 2021
Vancouver, British Columbia--(Newsfile Corp. - April 22, 2021) - NeonMind Biosciences Inc. (CSE: NEON) (OTC PINK: NMDBF) (FFE: 6UF) ("NeonMind"),...
Via
Newsfile
Topics
Death
Intellectual Property
Exposures
COVID-19
Death
Intellectual Property
Better Plant Announces Agreement with Faire Wholesale Marketplace for Jusu Home and Body Products
April 13, 2021
Vancouver, British Columbia--(Newsfile Corp. - April 13, 2021) - Better Plant Sciences Inc. (CSE: PLNT) (OTCQB: VEGGF) (FSE: YG3) ("Better...
Via
Newsfile
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Better Plant's Jusu Launches Twelve Natural Hair and Body Care Products
April 08, 2021
Vancouver, British Columbia--(Newsfile Corp. - April 8, 2021) - Better Plant Sciences Inc. (CSE: PLNT) (OTCQB: VEGGF) (FSE: YG3) ("Better...
Via
Newsfile
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.